ArticleJournal of thoracic disease2025
Research trends in epigenetic studies on lung cancer: a bibliometric and visual analysis of the past decade.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer remains one of the leading causes of cancer-related mortality worldwide, with epigenetic mechanisms playing a pivotal role in its pathogenesis and potential therapeutic targeting. This study aims to map research trends in lung cancer epigenetics through a bibliometric analysis. Methods: A comprehensive literature search was conducted in the Web of Science Core Collection (WoSCC) database, covering publications from 2015 to 2024. Key bibliometric indicators, including publication volume, citation counts, contributing countries, institutions, authors, journals, and keywords, were extracted and analyzed using VOSviewer, CiteSpace, and R (version 4.4.1). Results: A total of 12,117 publications were included in the final analysis, revealing a steady increase in research output over the past decade. China led in both publication count (n=8,935) and total citations (n=218,288). Among authors, Li Y exhibited the highest H-index [50], reflecting significant academic influence. Journals such as Conclusions: This bibliometric analysis highlights key research directions in lung cancer epigenetics, emphasizing molecular pathways as central themes. Future studies are expected to focus increasingly on the tumor microenvironment (TME), immune regulation, and metabolic reprogramming, underscoring the dynamic nature of this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.